济民健康振幅18.35%，上榜营业部合计净买入6607.95万元

Core Viewpoint - Jimin Health (603222) experienced a significant increase in stock price, reaching the daily limit, with a trading volume of 1.202 billion yuan and a fluctuation of 18.35% [1][2]. Trading Activity - The stock was listed on the trading board due to its daily fluctuation of 18.35%, with a total net purchase by brokerage seats amounting to 66.0795 million yuan [2]. - The top five brokerage seats accounted for a total transaction of 289 million yuan, with a buying amount of 178 million yuan and a selling amount of 111 million yuan, resulting in a net purchase of 66.0795 million yuan [2]. - The largest buying brokerage was Huafu Securities, with a purchase amount of 59.0385 million yuan, while the largest selling brokerage was CITIC Securities, with a selling amount of 46.6849 million yuan [2]. Stock Performance - Over the past six months, the stock has appeared on the trading board 13 times, with an average price increase of 2.92% the day after being listed and an average increase of 10.07% in the following five days [3]. - The stock saw a net inflow of 237 million yuan from major funds today, with a significant inflow of 263 million yuan from large orders, while smaller orders saw a net outflow of 25.9314 million yuan [3]. - In the past five days, the net inflow of major funds totaled 290 million yuan [3]. Financing and Margin Data - As of September 10, the stock's margin trading balance was 197 million yuan, with a financing balance of 197 million yuan and a securities lending balance of 115,000 yuan [3]. - In the past five days, the financing balance increased by 224,900 yuan, reflecting a growth rate of 0.11%, while the securities lending balance increased by 22,900 yuan, with a growth rate of 24.84% [3]. Financial Results - According to the semi-annual report released on August 21, the company achieved a revenue of 366 million yuan in the first half of the year, representing a year-on-year decline of 21.30%, and reported a net loss of 52.6959 million yuan [3].